FRTX — Fresh Tracks Therapeutics Share News
0.000.00%
Last trade - 00:00- $5.59m
- -$5.28m
- $8.01m
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx
U.S. STOCKS ON THE MOVE-Lululemon, Copper miners, Gold miners
U.S. STOCKS ON THE MOVE-Exscientia, Fresh Track Therapeutics, Pinterest
U.S. STOCKS ON THE MOVE-Exscientia, Fresh Track Therapeutics, Pinterest
Fresh Track Therapeutics gains as board approves liquidation plan
Brief: Fresh Tracks Therapeutics Announces Board Approval Of Plan Of Liquidation And Dissolution
Brief: Fresh Tracks Therapeutics Board Terminates CEO Andrew Sklawer
Brief: Fresh Tracks Announces $8.25 Mln Buyout Of Its Right To Receive Future Sofpironium Bromide Payments From Botanix
Brief: Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results
Brief: Fresh Tracks Therapeutics Inc Reports Q4 Revenue Of $2.1 Million
Brief: Fresh Tracks Therapeutics Inc - Currently Maintains Up To $1.0 Million In Cash Deposits At Svb
Fresh Tracks Therapeutics surges on positive data from lead drug
U.S. STOCKS ON THE MOVE-Diversey, DocuSign, Stitch Fix, Campbell Soup
U.S. STOCKS ON THE MOVE-WeWork, Silvergate, Rivian, CrowdStrike
Fresh Tracks Therapeutics surges on positive data from lead drug
Brief: Fresh Tracks Therapeutics Announces Positive Topline Results From Single And Multiple Ascending Dose Parts Of Phase 1 Study Of Oral Dyrk1a Inhibitor Frtx-02